Considering only 8.1% of potential patients enroll in clinical trials with an average of 20% of patients dropping out of clinical trials, and the average cost of running a Phase III clinical trial sitting at $55,716 a day, the financial significance of not recruiting and retaining patients becomes quite stark.
Utilizing in-home, at-site and technology solutions, can deliver faster and more efficient trials. The use of a site network will then broaden the reach of these trials – reaching untapped, diverse communities, and increasing trial reach, recruitment and retention.
Learn more about the importance of increasing diversity in clinical trials and how to do so by harnessing the power of Decentralized Clinical Trials.
